• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Wednesday 09/26/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

critical care

  • 3:09 PM

    Manufacturing Finalized and Site Recruitment Initiated PR Newswire, CTXR CRANFORD, N.J., Dec. 8, 2016 CRANFORD, N.J., Dec. 8, 2016 /PRNewswire/ — Citius Pharmaceuticals, Inc. (“Citius”) (OTC BB: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, provided details of its phase 3 trial for Mino-Lok™, an antibiotic lock solution used to salvage infected central venous catheters (CVCs) and to treat catheter related bloodstream infections (CRBSIs).  Mino-Lok is being developed as an adjunctive therapy for the treatment of

    Read more
  • 7:26 PM

    Two Contract Manufacturing Organizations Engaged to Produce Clinical Trial Material PR Newswire CRANFORD, N.J., Sept. 8, 2016 CRANFORD, N.J., Sept. 8, 2016, CTXR, /PRNewswire/ — Citius Pharmaceuticals, Inc. (“Citius”) (OTC QB: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that it has initiated manufacturing for the company’s clinical trial of Mino-Lok ™, an antibiotic lock solution used to salvage central venous catheters (CVCs) and to treat catheter related bloodstream infections (CRBSIs).

    Read more
  • 3:13 PM

    CRANFORD, N.J., Sept. 7, 2016, CTXR, /PRNewswire/ — Citius Pharmaceuticals, Inc. (“Citius”) (OTC QB: CTXR), a specialty pharmaceutical company dedicated to developing and commercializing adjunctive cancer care and critical care drug products, announced today that its Chairman, Len Mazur, will present at the Rodman & Renshaw 18th Annual Global Investment Conference. The Conference will be held on September 11-13, 2016 at the Lotte New York Palace Hotel, New York City. Event: Rodman & Renshaw 18th Annual Global Investment Conference Location:

    Read more
  • 4:42 PM

    CRANFORD, N.J., Aug. 23, 2016 /PRNewswire/ — Citius Pharmaceuticals, Inc. (“Citius”) (OTC BB: CTXR), a specialty pharmaceutical company dedicated to developing and commercializing adjunctive cancer care and critical care drug products, announced completion of market research with in-depth interviews on patient-reported signs and symptoms of hemorrhoids and treatment outcomes with its Hydro-Lido product. Citius and the market research group conducted in-depth, in-person and telephonic interviews of patients who were diagnosed with grade II and grade III hemorrhoid disease. The interviews

    Read more
  • 3:27 PM

    Sep 10, 2014 (eTeligis.com via COMTEX) — TUSTIN, CA, United States, via ETELIGIS INC., 09/10/2014 – – Premier Holding Corporation (OTCQB: PRHL), an energy reseller in deregulated markets and provider of energy efficient solutions, announces that it has signed a Definitive Agreement to acquire 85% of Lexington Power and Light, LLC. Premier also announces that the application to be recognized as majority owner of a power supplier by the Federal Energy Regulatory Commission (FERC) was submitted on August 26th, 2014.

    Read more
Public Wire Banner